Endometriosis
No direct peptide trials; GLP-1 emerging, GnRH agonists standard. Repair peptides are extrapolation.
Decision support, not prescription. You decide.
Monitor — GLP-1 constipation risk in bowel-endo
GLP-1 constipation is problematic in bowel-endometriosis/resection patients.
Candidate agents
4 agents · ranked by role, then evidenceMonitor — GLP-1 constipation risk in bowel-endo
GLP-1/GIP framed as multi-axis adjuvant for refractory endo; no endo-specific RCT.
PMID 424499529 reports · Microdosed for inflammation/pain post-excision; ovulation pain gone, mood/energy up
VIP is UP-regulated and pain-associated in endo tissue — giving VIP is counterproductive.
PMID 29675846No endometriosis-specific studies exist; anti-inflammatory extrapolation only.
AMPK activation; anti-inflammatory/anti-proliferative — regresses endometriotic implants and lowers VEGF/MMP-9 in animal models. Mechanistic + preclinical only; no human endometriosis RCT.
PMID 35158846Matching protocol templates
Browse all →Body recomposition, injury recovery, fat trimming
Skin tightening, collagen repair, wound healing
Gut healing, barrier repair, anti-inflammatory
The platform surfaces evidence, community signal and peer outcomes with enforced cautions. It never decides treatment — the licensed clinician orders labs, writes notes, and prescribes.